Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Luminex Corp. LMNX -- Ignore unavailable to you. Want to Upgrade?

To: Hungry Investor who wrote (34)	4/25/2000 10:07:00 AM
From: Hamilton Rogers	Read Replies (1) \| Respond to of 47

Warburg Starts LMNX As Strong Buy, Target $50 NEW YORK, April 25 (Reuters) - Warburg Dillon Read said Tuesday it had started coverage of Luminex Corp. , which develops a technology that simplifies biological testing, with a strong buy rating and set a $50 price target on the shares. -- said Luminex's technology is used in three key market segments: drug discovery, biomedical research and diagnostics. "We believe that all three markets will experience very rapid growth in the future...," Warburg said in a report. -- report said that as of February, Luminex had placed about 114 systems with about 63 customers. -- predicted that Luminex will be profitable in 2001. -- Shares of Luminex closed on Monday at 19. ((--New York Newsroom 212-859-1700)) REUTERS Rtr 09:08 04-25-00